Braftovi 75 mg (Encorafenib CAPSULE) 75 MG

BRAFTOVI 75 MG capsules are a prescription medication used in combination therapy for certain types of cancer. This oral treatment is designed to target specific genetic mutations, offering a targeted approach to cancer care.

Strength

75 MG

Manufacturer / TM Owner

PFIZER CANADA ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

BRAFTOVI 75 MG capsules are primarily used in combination with other medications to treat advanced or metastatic cancers that harbor specific BRAF mutations. This targeted therapy is often part of a broader treatment plan for conditions like melanoma, colorectal cancer, and other solid tumors. Patients should consult their healthcare provider to determine if this medication is suitable for their condition.

Side Effects

Common effects of BRAFTOVI 75 MG capsules may include fatigue, nausea, and skin-related issues such as rash or dry skin. Some individuals might experience changes in blood pressure or liver function. It's important to monitor these effects and report any severe or persistent symptoms to a healthcare professional.

Precautions & Warnings

BRAFTOVI 75 MG capsules should be handled with care, following the prescribed dosage and administration guidelines. Patients should avoid grapefruit or grapefruit juice, as it can affect the medication's effectiveness. Regular blood tests may be required to monitor liver function and other potential side effects.

Avoid Interactions

BRAFTOVI 75 MG capsules can interact with a variety of medications, including those metabolized by the liver's CYP3A4 enzyme. This includes certain antidepressants, antibiotics, and antifungal medications. Alcohol and other substances that affect liver function should be avoided to prevent adverse interactions.

Frequently Asked Questions

BRAFTOVI 75 MG capsules are used in combination with other medications to treat advanced or metastatic cancers with specific BRAF mutations.

BRAFTOVI 75 MG capsules should be taken orally, following the dosage and administration guidelines provided by a healthcare professional.

Common side effects may include fatigue, nausea, skin rash, and changes in blood pressure or liver function.

BRAFTOVI 75 MG can interact with various medications, particularly those metabolized by the liver's CYP3A4 enzyme. Consult a healthcare provider before combining with other treatments.

It is generally advised to avoid alcohol while taking BRAFTOVI 75 MG, as it can affect liver function and potentially interact with the medication.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.